A sensitive assay to measure biomarker glycosylation demonstrates increased fucosylation of prostate specific antigen (PSA) in patients with prostate cancer compared with benign prostatic hyperplasia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples